Principia BioPharma principiabio.com


Public lists: BIO 2016 (619)

Principia Biopharma is a biopharmaceutical company focused on discovering and developing first-in-class small molecule drugs within the fields of autoimmune disease and oncology that are potent, safe and have antibody-like specificity for their targets. Expanding on technology originally licensed from the University of California, San Francisco, the company has built a drug discovery and development engine broadly utilizing its technology around reversible covalent small molecule inhibitors. Thi...Show all

Principia Biopharma is a biopharmaceutical company focused on discovering and developing first-in-class small molecule drugs within the fields of autoimmune disease and oncology that are potent, safe and have antibody-like specificity for their targe...Show all

Company (Alive / Active)

All investors data 6 Investors

Phone: 650-416-7700

Fax:

400 East Jamie Court
Suite 302
 South San Francisco, 94080
 California, United States

Latest News

See more competitors data Competitors
Total Funding Date of Last Funding
Principia BioPharma $89.9M Aug 4, 2015

Web Traffic

Rank

Show (-10)

Engagement (PVPU)

Show (+1%)

Domain Authority Score
Show
Page Views Per Million (PVPM)
Show
Reach Per Million
Show

SEO Statistics

Domain Authority Score Show
Page Authority Score Show
No. External Links Show
No. Links Show

Web Traffic Statistics - Growth

Per Week Per Month Per 6 Months Per Year
Rank Login to see details
Page Views Per Million Login to see details
Page Views Per User Login to see details
Reach Per Million Login to see details

Related Principia BioPharma Jobs

jobs by Indeed job search

Investors

Investor Investor Type Location Participating Rounds
See all 6 investors

Board Members

Name Firm
Login to see detailsSofinnova Ventures
Login to see detailsNew Leaf Venture Partners
Login to see detailsSR One
Login to see detailsOrbiMed Advisors
There is no Competitors data available for this company. Please select another tab.

Patents

Title Application Date Patent Date Status
(Patent / Application)
Quinolone derivatives as fibroblast growth factor inhibitors May 07, 2014 Apr 25, 2017 Patent
Kinase inhibitors May 16, 2012 Feb 28, 2017 Patent
Benzimidazole derivatives as itk inhibitors Aug 27, 2013 Feb 21, 2017 Patent
Treatment of dry eye Jul 31, 2013 Feb 21, 2017 Patent
Quinolone derivatives as fibroblast growth factor receptor inhibitors Mar 22, 2016 Feb 14, 2017 Patent
See all 24 patents